Search Within

GME, Medicine

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (183)
  2. Journal Article (144)
  3. Research Letter (9)
  4. Review (3)
  5. Correspondence (1)
Groups
  1. Biostatistics Service (340)
  2. Epidemiology and Biostatistics (340)
  3. Graduate Medical Education (340)
  4. Department of Medicine (328)
  5. Hematologic Malignancies, Division of (224)
  6. Hematology-Oncology Fellows (214)

More Groups

People
  1. Gunjan Shah (93)
  2. Michael Scordo (93)
  3. Andriy Derkach (89)
  4. Sergio Giralt (84)
  5. Malin Hultcrantz (69)
  6. Kylee Maclachlan (67)

More People

Years
  1. 2025 (23)
  2. 2024 (85)
  3. 2023 (114)
  4. 2022 (72)
  5. 2021 (24)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (76)
  2. Blood (64)
  3. Clinical Lymphoma, Myeloma and Leukemia (24)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (12)
  6. Blood Advances (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. American Society of Hematology (74)
  3. Elsevier Inc. (45)
  4. Nature Publishing Group (29)
  5. Oxford University Press (20)
  6. American Association for Cancer Research (17)

More Publishers

Results (340)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical Factors but not somatic mutations predict for survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplant: Analysis of the North American myelofibrosis transplant outcome (NAMTO) study
    Meeting Abstract

    Ajufo, H.; Derkach, A.; Rampal, R. K.; Famulare, C.; Nemirovsky, D.; Chervin, J.; Ho, V.; Gupta, V.; Viswabandya, A.; Deeg, H. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of sequential CD19-directed therapies in relapsed and refractory large B cell lymphoma
    Meeting Abstract

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M. H.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G.; Romancik, J. T.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of symptom benefit and transfusion response on survival in myelofibrosis patients treated with pacritinib: PERSIST-2 landmark survival analysis
    Meeting Abstract

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C. N.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A. T.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Detection of CAR-T cell persistence with digital droplet PCR: Correlation of in vivo expansion with clinical outcomes in a cohort of B-cell lymphoma patients
    Meeting Abstract

    Cassanello, G.; Borsu, L.; Arcila, M. E.; Yao, J.; Boroujeni, A. M.; Ewalt, M.; Patel, U.; Chan, R.; Gray, B.; Luna De Abia, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    Meeting Abstract

    Bewersdorf, J. P.; Derkach, A.; Masarova, L.; Pemmaraju, N.; Stein, E. M.; Mauro, M.; Rampal, R. K.; Bose, P.
    Blood (2023)

    Fulltext@MSK | Save
  • Analysis of 3,843 unrelated donors (URD) for 455 allograft candidates reveals low URD availability with marked racial/ ethnic disparities: Major implications for transplant center & registry operations
    Meeting Abstract

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S. M.; Nhaissi, M.; Rapoport, C.; Chinapen, S.; Kelly, A.; Wells, D.; more...
    Blood (2023)

    Fulltext@MSK | Save